Home
/
Fulcrum Therapeutics, Inc. (FULC)
Home
News
General News
General Crypto News
Facebook
Amazon
Apple
Netflix
Google
Insights
Market Performance
About us
About us
Terms and Conditions
Privacy Policy
Contact us
My Account
2 Stocks to Load Up On During This Correction
UBER | -2.03%
CELH | -0.04%
Looking Ahead to Tesla's Earnings: What Can We Expect?
TSLA | 12.06%
Should We Buy This Dip in NVDA and Semis?
NVDA | -3.33%
TSM | -0.35%
2 Earnings to Watch for Next Week
TSM | -0.35%
BAC | -0.13%
2 Trillion Dollar Companies in the Making
COIN | -5.10%
CRWD | -0.68%
2 Stocks That Could Explode in Q2
CELH | -0.04%
SQ | -1.57%
Is Tesla Back? Has TSLA Stock Finally Bottomed?
TSLA | 12.06%
FULC | Fulcrum Therapeutics, Inc.
1D
5D
1M
3M
1Y
5Y
$
Current Price
$0
Today (USD)
%
Today %
Fulcrum Therapeutics Latest Report On Its Sickle Cell Disease Trials
The Phase 1b trial for the drug remains on track and will be initiated soon.
By Precious Njoku |
2 years ago
FULC
Load More
